Identification of cell type specific ACE2 modifiers by CRISPR screening.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
03 2022
Historique:
received: 03 09 2021
accepted: 15 02 2022
revised: 17 03 2022
pubmed: 2 3 2022
medline: 29 3 2022
entrez: 1 3 2022
Statut: epublish

Résumé

SARS-CoV-2 infection is initiated by binding of the viral spike protein to its receptor, ACE2, on the surface of host cells. ACE2 expression is heterogeneous both in vivo and in immortalized cell lines, but the molecular pathways that govern ACE2 expression remain unclear. We now report high-throughput CRISPR screens for functional modifiers of ACE2 surface abundance. In liver-derived HuH7 cells, we identified 35 genes whose disruption was associated with a change in the surface abundance of ACE2. Enriched among these ACE2 regulators were established transcription factors, epigenetic regulators, and functional networks. We further characterized individual HuH7 cell lines with disruption of SMAD4, EP300, PIAS1, or BAMBI and found these genes to regulate ACE2 at the mRNA level and to influence cellular susceptibility to SARS-CoV-2 infection. Orthogonal screening of lung-derived Calu-3 cells revealed a distinct set of ACE2 modifiers comprised of ACE2, KDM6A, MOGS, GPAA1, and UGP2. Collectively, our findings clarify the host factors involved in SARS-CoV-2 entry, highlight the cell type specificity of ACE2 regulatory networks, and suggest potential targets for therapeutic development.

Identifiants

pubmed: 35231079
doi: 10.1371/journal.ppat.1010377
pii: PPATHOGENS-D-21-01806
pmc: PMC8929698
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010377

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL148552
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034933
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM139823
Pays : United States

Commentaires et corrections

Type : UpdateOf

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Commun. 2021 Mar 12;12(1):1661
pubmed: 33712601
Sci Rep. 2021 Aug 5;11(1):15900
pubmed: 34354120
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Genes Dev. 1998 Jul 15;12(14):2153-63
pubmed: 9679060
Cell Mol Gastroenterol Hepatol. 2021;11(1):181-184
pubmed: 32810597
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2681-2690
pubmed: 30679277
Nature. 1999 Sep 30;401(6752):480-5
pubmed: 10519551
Nature. 2022 Feb;602(7898):657-663
pubmed: 35016194
Nat Genet. 2020 Dec;52(12):1283-1293
pubmed: 33077916
Nat Rev Microbiol. 2017 Jun;15(6):351-364
pubmed: 28420884
J Biol Chem. 2004 May 28;279(22):22857-65
pubmed: 15028714
Nature. 2022 Feb;602(7898):676-681
pubmed: 35016198
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
Cell Rep. 2021 Apr 6;35(1):108959
pubmed: 33811811
Front Mol Biosci. 2020 Oct 16;7:568954
pubmed: 33195414
Sci Adv. 2021 Mar 19;7(12):
pubmed: 33608249
Genome. 2021 Apr;64(4):386-399
pubmed: 33086021
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Biochim Biophys Acta. 2013 Nov;1829(11):1225-35
pubmed: 24100303
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Cell. 2021 Jan 7;184(1):106-119.e14
pubmed: 33333024
Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5
pubmed: 33357464
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Nucleic Acids Res. 2014 Aug;42(14):8845-60
pubmed: 25053837
Cell. 2020 Dec 10;183(6):1735
pubmed: 33306958
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
PLoS Genet. 2021 Jan 29;17(1):e1009285
pubmed: 33513160
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93
pubmed: 15897467
Elife. 2020 Nov 09;9:
pubmed: 33164751
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
Nat Genet. 2020 Dec;52(12):1294-1302
pubmed: 33077915
Nat Commun. 2018 Dec 21;9(1):5416
pubmed: 30575746
Cell. 2021 Jan 7;184(1):120-132.e14
pubmed: 33382968
Genome Biol. 2014;15(12):554
pubmed: 25476604
Epigenetics. 2021 Mar;16(3):263-270
pubmed: 32686577
Int J Biol Sci. 2018 Jan 12;14(2):111-123
pubmed: 29483830
Cell. 2021 Jan 7;184(1):92-105.e16
pubmed: 33147445
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):
pubmed: 34413211
Cell. 2020 Jul 9;182(1):50-58.e8
pubmed: 32516571
J Virol. 2021 Jan 29;:
pubmed: 33514628
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Nature. 2020 Jul;583(7818):830-833
pubmed: 32380511
Elife. 2018 Sep 25;7:
pubmed: 30251625
Kidney Int. 2020 Dec;98(6):1502-1518
pubmed: 33038424
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Nat Genet. 2021 Apr;53(4):435-444
pubmed: 33686287
PLoS One. 2020 Oct 28;15(10):e0240647
pubmed: 33112891
Science. 2020 Dec 4;370(6521):
pubmed: 33060197
Genes Dev. 1998 Jul 15;12(14):2114-9
pubmed: 9679056
Nat Immunol. 2020 Nov;21(11):1327-1335
pubmed: 32839612
Nature. 1992 Jun 4;357(6377):420-2
pubmed: 1350662

Auteurs

Emily J Sherman (EJ)

Department of Internal Medicine, Division of Hospital Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.

Carmen Mirabelli (C)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.

Vi T Tang (VT)

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States of America.
Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.

Taslima G Khan (TG)

Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Chemical Biology Program, University of Michigan, Ann Arbor, Michigan, United States of America.

Kyle Leix (K)

Department of Internal Medicine, Division of Hospital Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.

Andrew A Kennedy (AA)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, United States of America.

Sarah E Graham (SE)

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.

Cristen J Willer (CJ)

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America.
Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, United States of America.

Andrew W Tai (AW)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, United States of America.
VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America.

Jonathan Z Sexton (JZ)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, United States of America.
Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, United States of America.

Christiane E Wobus (CE)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.

Brian T Emmer (BT)

Department of Internal Medicine, Division of Hospital Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH